These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20095947)

  • 21. Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.
    Todo T; Martuza RL; Rabkin SD; Johnson PA
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6396-401. PubMed ID: 11353831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term inducible expression in striatal neurons from helper virus-free HSV-1 vectors that contain the tetracycline-inducible promoter system.
    Gao Q; Sun M; Wang X; Zhang GR; Geller AI
    Brain Res; 2006 Apr; 1083(1):1-13. PubMed ID: 16545782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization by Replication-Competent Controlled Herpesvirus Vectors.
    Bloom DC; Tran RK; Feller J; Voellmy R
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses.
    Hocknell PK; Wiley RD; Wang X; Evans TG; Bowers WJ; Hanke T; Federoff HJ; Dewhurst S
    J Virol; 2002 Jun; 76(11):5565-80. PubMed ID: 11991985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equine herpesvirus 1 gene 12 can substitute for vmw65 in the growth of herpes simplex virus (HSV) type 1, allowing the generation of optimized cell lines for the propagation of HSV vectors with multiple immediate-early gene defects.
    Thomas SK; Lilley CE; Latchman DS; Coffin RS
    J Virol; 1999 Sep; 73(9):7399-409. PubMed ID: 10438830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of foreign genes in adult rats' central nervous system by use of defective herpes simplex virus type 1 vectors].
    Yang T; Wang X; Yan Z; Hou Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):306-10. PubMed ID: 15617234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0.
    Brehm M; Samaniego LA; Bonneau RH; DeLuca NA; Tevethia SS
    Virology; 1999 Apr; 256(2):258-69. PubMed ID: 10191191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response to herpes simplex virus and gamma134.5 deleted HSV vectors.
    Broberg EK; Hukkanen V
    Curr Gene Ther; 2005 Oct; 5(5):523-30. PubMed ID: 16250892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of replication-competent and -defective HSV vectors.
    Goins WF; Krisky DM; Wechuck JB; Wolfe D; Huang S; Glorioso JC
    Cold Spring Harb Protoc; 2011 May; 2011(5):pdb.prot5615. PubMed ID: 21536761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replication-defective genomic herpes simplex vectors: design and production.
    Burton EA; Bai Q; Goins WF; Glorioso JC
    Curr Opin Biotechnol; 2002 Oct; 13(5):424-8. PubMed ID: 12459332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity.
    Toda M; Martuza RL; Kojima H; Rabkin SD
    J Immunol; 1998 May; 160(9):4457-64. PubMed ID: 9574551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the lacZ reporter gene in the rat basal forebrain, hippocampus, and nigrostriatal pathway using a nonreplicating herpes simplex vector.
    Maidment NT; Tan AM; Bloom DC; Anton B; Feldman LT; Stevens JG
    Exp Neurol; 1996 May; 139(1):107-14. PubMed ID: 8635556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of the S component inverted repeat sequence c' and the nonessential genes U(S)1 through U(S)5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system.
    Rasty S; Poliani PL; Fink DJ; Glorioso JC
    J Neurovirol; 1997 Aug; 3(4):247-64. PubMed ID: 9291233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral activity of herpes simplex virus vectors expressing murine alpha 1-interferon.
    Mester JC; Pitha PM; Glorioso JC
    Gene Ther; 1995 May; 2(3):187-96. PubMed ID: 7614249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.
    Lim F; Hartley D; Starr P; Lang P; Song S; Yu L; Wang Y; Geller AI
    Biotechniques; 1996 Mar; 20(3):460-9. PubMed ID: 8679207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis.
    Poliani PL; Brok H; Furlan R; Ruffini F; Bergami A; Desina G; Marconi PC; Rovaris M; Uccelli A; Glorioso JC; Penna G; Adorini L; Comi G; 't Hart B; Martino G
    Hum Gene Ther; 2001 May; 12(8):905-20. PubMed ID: 11387056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced reporter gene expression in the rat brain from helper virus-free HSV-1 vectors packaged in the presence of specific mutated HSV-1 proteins that affect the virion.
    Yang T; Zhang GR; Zhang W; Sun M; Wang X; Geller AI
    Brain Res Mol Brain Res; 2001 May; 90(1):1-16. PubMed ID: 11376851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herpes simplex virus type 1 Us3 gene deletion influences toll-like receptor responses in cultured monocytic cells.
    Peri P; Mattila RK; Kantola H; Broberg E; Karttunen HS; Waris M; Vuorinen T; Hukkanen V
    Virol J; 2008 Nov; 5():140. PubMed ID: 19025601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HSV as a vector in vaccine development and gene therapy.
    Marconi P; Argnani R; Berto E; Epstein AL; Manservigi R
    Hum Vaccin; 2008; 4(2):91-105. PubMed ID: 18496918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurons differentially control expression of a herpes simplex virus type 1 immediate-early promoter in transgenic mice.
    Mitchell WJ
    J Virol; 1995 Dec; 69(12):7942-50. PubMed ID: 7494307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.